Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Gliadel

Gliadel is a medicine containing the active ingredient(s) carmustine. On this page you will find out more about Gliadel, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: carmustine

Information for medicine and pack size:
Gliadel 7.7 mg implant, 8

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

GLIADEL is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation. GLIADEL is also indicated for use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme (GBM) for whom surgical resection is indicated.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Off white to pale yellow implant approximately 1.45cm in diameter and 1mm thick.
Dosage Form Implant
Route of administration Intracranial
Medicine schedule
8 implants: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Sachet
Storage temperature No information available
Storage conditions Store in a deep freeze
Life time 4 Years
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 November 2017

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 3 results

Gliadel Implant - myDr.com.au

Gliadel Implant - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Gliadel Implant (Carmustine) information | myVMC

Gliadel Implant is an anti-cancer treatment against myeloma and Hodgkin's and non-Hodgkin's lymphoma. It contains carmustine, an alkylating agent.

Read more on myVMC – Virtual Medical Centre website

BiCNU | myVMC

Carmustine is used in the palliative management, alone or in combination with other agents, of the following cancers: malignant glioma (type of brain tumour) multiple myeloma (often in combination with prednisone) Hodgkins disease Non-Hodgkins lymphoma The implantable preparation of Carmustine, Gliadel Implant, is used to prolong life in patients with recurrent glioblastoma multiforme (a malignant brain tumour) who have had surgery

Read more on myVMC – Virtual Medical Centre website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback